131I治疗Graves病疗效及影响因素分析(3)
 |
| 第1页 |
参见附件(2052KB，3页)。
[3]Ripley SD, John E, Freitas, Nagle CE. Is Thyroid scintigraphy necessary before I-131 therapy for hyperthyroidism concise communication[J]. J Nucl Med, 1982, 23: 103-107
[4]B Pena, S Arum, M Cross, et al.123I Thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers[J].J Clin Endocrinol Metab, 2006, 91(2): 506-510.
[5]H Zaidi. Comparative methods for quantifying thyroid volume using planar imaging and SPECT[J]. J Nucl Med, 2004, 45: 626-633.
[6]Nielsen VE, Bonnema SJ, Boel-Jorgensen H, et al. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial[J].J Clin Endocrinol Metab, 2005, 90: 79-83.
[7]McDougall R, Iagaru A. Antithyroid drugs and radioiodine and the absence of evidence[J].J Nucl Med, 2007, 48: 1403-1404.
[8]Walter M, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials[J]. BMJ, 2007, 334: 514-514.
[9]Nielsen V, Bonnema S, Boel-Jorgensen H, et al. Stimulation with 0.3-mg recombinant human thyrotropin prior to Iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial[J].Arch Intern Med, 2006, 166: 1476-1482.
[10]Cohen O, Ilany J, Hoffman C, et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients[J].Eur J Endocrinol,2006, 154: 243-252.
(收稿日期：2008-06-16)
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(2052KB，3页)。